Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary intraocular lymphoma].

S E Coupland1, H Heimann

  • 1Institut für Pathologie, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin. secoupland@yahoo.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|February 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

ESMO open·2026
Same author

Choroidal biopsies; a review and optimised approach.

Eye (London, England)·2022
Same author

Proton beam radiotherapy for choroidal and ciliary body melanoma in the UK-national audit of referral patterns of 1084 cases.

Eye (London, England)·2022
Same author

Imaging characteristics of idiopathic scleroma: a retrospective case series and review of the literature.

Eye (London, England)·2022
Same author

Altered Nuclear Expression of the Deubiquitylase BAP1 Cannot be Used as a Prognostic Marker for Canine Melanoma.

Journal of comparative pathology·2018
Same author

[Primary vitreoretinal lymphoma].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2018
Same journal

["DOG 2020 online" - for the first time in the von Graefe year].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2024
Same journal

[Are organ and co-cultures an alternative to animal models in ophthalmology?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Pediatric corneal opacities : Even small improvements provide lifelong help].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Myxoma of the conjunctiva].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
See all related articles

Primary intraocular lymphoma (PIOL) is a rare cancer affecting the eye, often presenting as difficult-to-treat uveitis. Early diagnosis and treatment of PIOL improve patient survival rates.

Area of Science:

  • Ophthalmology
  • Hematology
  • Oncology

Context:

  • Primary intraocular lymphoma (PIOL) is a rare extranodal Non-Hodgkin lymphoma (NHL) affecting ocular structures.
  • PIOL frequently co-occurs with primary central nervous system lymphoma (PCNSL) and often mimics steroid-resistant uveitis.
  • Diagnosis of PIOL is challenging, necessitating advanced techniques beyond standard clinical evaluation.

Purpose:

  • To review the diagnostic modalities and treatment strategies for primary intraocular lymphoma (PIOL).
  • To highlight the challenges in diagnosing PIOL and its association with PCNSL.
  • To discuss current and emerging therapeutic approaches for PIOL.

Summary:

  • PIOL, predominantly diffuse large B-cell lymphoma, involves ocular tissues and can present as resistant uveitis.

Related Experiment Videos

  • Diagnostic methods include cytological examination of vitreal aspirates, polymerase chain reaction (PCR) for gene rearrangements, and chorioretinal biopsies.
  • Treatment involves systemic chemotherapy, with radiotherapy and intraocular methotrexate used for ocular recurrences.

    • Impact:

    • Improved diagnostic accuracy through advanced techniques like PCR and biopsies aids in timely management.
    • Current treatments, including systemic chemotherapy and targeted intraocular therapies, are enhancing survival rates for PIOL/PCNSL patients.
    • Earlier diagnosis and multimodal treatment strategies are crucial for improving the prognosis of this rare ocular malignancy.